Acupuncture for Major Depressive Disorder

A Systematic Review

Melony E. Sorbero, Kerry Reynolds, Benjamin Colaiaco, Susan L. Lovejoy, Coreen Farris, Christine Anne Vaughan, Jennifer Sloan, Ryan Kandrack, Eric Apaydin, Patricia M. Herman

ResearchPublished Oct 7, 2015

RAND researchers conducted a systematic review that synthesized evidence from randomized controlled trials of acupuncture — used adjunctively or as monotherapy — to assess its efficacy and safety in treating adults with major depressive disorder.

Outcomes of interest included depressive symptoms, response to treatment, remission, relapse, health-related quality of life, and adverse events. Study details were documented in detailed evidence tables and summarized in a narrative synthesis. The quality of evidence was assessed using the Grades of Recommendation, Assessment, Development, and Evaluation (or GRADE) approach.

In total, 18 studies met inclusion criteria. Eleven of these studies focused on acupuncture as a monotherapy, and seven examined its use as an adjunctive therapy to antidepressants or treatment as usual. We found that monotherapy acupuncture may be superior to waitlist, but the methodological quality of the studies was generally poor, with limited blinding, high attrition, and limited use of intention-to-treat analysis. The limited evidence suggests a higher rate of responders with adjunctive acupuncture plus antidepressants than with antidepressants alone, but the studies were of poor quality. Findings for effect estimates of acupuncture compared with other comparators are inconclusive. Reported adverse events were typically mild in nature, but the assessment lacked rigor and studies were not designed to detect rare events.

Key Findings

Evidence for Using Needle Acupuncture to Treat Major Depressive Disorder (MDD) Is Limited

  • We identified 18 randomized controlled trials that examined acupuncture in the treatment of MDD. We found that the methodological quality of the studies was generally poor, with limited blinding, high attrition, and limited use of intention-to-treat analysis.
  • The limited evidence suggests a higher rate of responders with adjunctive acupuncture plus antidepressants than with antidepressants alone, but the studies were of poor quality (low quality of evidence).
  • Monotherapy acupuncture may be superior to waitlist (low quality of evidence), but findings for effect estimates compared with other comparators are inconclusive.
  • Few studies reported on patients achieving remission. The effect of acupuncture on relapse rates could not be determined. Too few studies assessed quality of life to estimate treatment effects.
  • Reported adverse events were typically mild in nature, but the assessment lacked rigor and studies were not designed to detect rare events.

Recommendations

  • Future studies should improve on the weaknesses pervasive in the current body of work, including a lack of patient blinding to assigned conditions, suboptimal participant retention, and the lack of intention-to-treat analyses.
  • Further research examining the effect of acupuncture on depression should include large samples that allow results to be stratified by disease severity, focus on better understanding whether there is a minimum frequency or duration of acupuncture for it to be effective, and include measures of health-related quality of life.

Topics

Document Details

Citation

RAND Style Manual
Sorbero, Melony E., Kerry Reynolds, Benjamin Colaiaco, Susan L. Lovejoy, Coreen Farris, Christine Anne Vaughan, Jennifer Sloan, Ryan Kandrack, Eric Apaydin, and Patricia M. Herman, Acupuncture for Major Depressive Disorder: A Systematic Review, RAND Corporation, RR-1135-OSD, 2015. As of September 18, 2024: https://www.rand.org/pubs/research_reports/RR1135.html
Chicago Manual of Style
Sorbero, Melony E., Kerry Reynolds, Benjamin Colaiaco, Susan L. Lovejoy, Coreen Farris, Christine Anne Vaughan, Jennifer Sloan, Ryan Kandrack, Eric Apaydin, and Patricia M. Herman, Acupuncture for Major Depressive Disorder: A Systematic Review. Santa Monica, CA: RAND Corporation, 2015. https://www.rand.org/pubs/research_reports/RR1135.html.
BibTeX RIS

This research was sponsored by the Office of the Secretary of Defense and the Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury and conducted within the Forces and Resources Policy Center of the RAND National Defense Research Institute, a federally funded research and development center sponsored by the Office of the Secretary of Defense, the Joint Staff, the Unified Combatant Commands, the Navy, the Marine Corps, the defense agencies, and the defense Intelligence Community.

This publication is part of the RAND research report series. Research reports present research findings and objective analysis that address the challenges facing the public and private sectors. All RAND research reports undergo rigorous peer review to ensure high standards for research quality and objectivity.

This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.